FDA Reverses Decision About Moderna Flu Vaccine
Andrew Egger and Jonathan Cohn give their takes on the stunning back-and-forth at the FDA over Moderna’s new mRNA flu vaccine, why the agency initially refused to even review the application, and what the sudden reversal says about political pressure inside the Trump administration’s health agencies.
Andrew Egger and Jonathan Cohn give their takes on the stunning back-and-forth at the FDA over Moderna’s new mRNA flu vaccine, why the agency initially refused to even review the application, and what the sudden reversal says about political pressure inside the Trump administration’s health agencies.
Tickets are now on sale for our LIVE shows in Dallas on March 18 and in Austin on March 19. Plus, we have a handful of seats still available for our second show in Minneapolis on February 18: https://www.thebulwark.com/p/bulwark-events
As always: Watch, listen, and leave a comment. Bulwark+ Takes is home to short videos, livestreams, and event archives exclusively for Bulwark+ members.
Add Bulwark+ Takes feed to your player of choice, here.
Join Bulwark+ to unlock the rest
Become a paying member of The Bulwark to get access to this post and other subscriber-only content. A subscription gets you:
- Unlimited access to articles and newsletters including The Triad by JVL and Receipts by Catherine Rampell.
- Ad-free editions of our shows (with transcripts) and member-only shows like The Secret Podcast.
- Plus community chats and commenting features. Your support helps keep our work sustainable and available to those who cannot afford a membership. Cancel anytime.